Obhan & Associates advises Ace Cardiopathy on 60% stake sale to Entero Healthcare

Ace Cardiopathy Solutions Private Limited is selling 60% of its shareholding to Entero Healthcare Solutions Limited, for a cost ranging between ₹59.30 Crore to ₹77.10 Crore, subject to adjustments for net debt, normalized working capital, and achievement of certain conditions.

Obhan & Associates advised Ace Cardiopathy on this transaction. The Firm advised on various legal aspects of the transaction, including transaction structuring, drafting and negotiation of definitive agreements and ancillary documents, as well as assistance through closing and post-closing formalities.

The transaction was led by a team comprising Ashima Obhan (Senior Partner), Shuchi Dutta (Senior Associate), and Aakanksha Singh (Associate).

Ace Cardiopathy is a leading player in the cardiovascular medical solutions space. The acquisition is expected to accelerate Ace Cardiopathy's growth by leveraging Entero Healthcare's established distribution network and market reach.

For Entero Healthcare, Ace Cardiopathy's expertise in the distribution of cardiovascular health equipment would strengthen its position in the rapidly expanding healthcare and life sciences sector.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.